FIELD: medicine, dermatology. SUBSTANCE: method involves the external use of the preparation prepared from pig skin (molecular mass is 1.4-15 kDa) at concentration 100-300 mcg/ml. Preparation inhibits proliferation and stimulates human keratinocytes differentiation and has water-soluble base that does not inactivate the preparation. EFFECT: elimination of by-side effects of preparation. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EXTERNAL TREATMENT OF PSORIATIC ONYCHODYSTROPHY | 2011 |
|
RU2462232C1 |
| METHOD OF PSORIASIS TREATMENT | 1993 |
|
RU2061495C1 |
| METHOD OF CURE FOR ERYTHRODERMA PSORIATICUM | 2008 |
|
RU2369394C1 |
| METHOD OF PSORIASIS TREATMENT | 2007 |
|
RU2361605C2 |
| METHOD OF TREATING PSORIATIC ERYTHRODERMA | 2011 |
|
RU2496498C2 |
| AGENT FOR COMPLEX THERAPY OF CHRONIC DERMATOSIS, PSORIASIS, ATOPIC DERMATITIS, ECZEMA AND XERODERMIA AND METHOD OF TREATMENT OF CHRONIC DERMATOSIS | 2001 |
|
RU2196585C2 |
| METHOD OF TREATING PATIENTS WITH PSORIASIS | 2009 |
|
RU2411049C1 |
| METHOD OF TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA | 2018 |
|
RU2722396C2 |
| METHOD OF TREATING PSORIASIS VULGARIS | 2012 |
|
RU2476228C1 |
| METHOD OF ISOLATING IMMUNOLOGICALLY ACTIVE SUBSTANCES FROM NEURO- SECRETORY STRUCTURES OF MAMMALIAN BRAIN EPITHALAMUS | 1996 |
|
RU2126258C1 |
